ARE offers a contrarian Buy opportunity, trading at a deep discount with a well-covered 7.5% dividend yield and resilient FFO per share. While sector demand is soft, ARE's fundamentals are solid: diversified tenant base, limited 2025 lease expirations and strong pre-leasing on new developments. Elevated leverage and a large development pipeline add risk, but long-dated debt maturities and strong fixed charge coverage provide financial flexibility.
Office buildings are experiencing accelerating bifurcation; quality assets in strong markets are outperforming as obsolete buildings face decline or conversion. We capitalized on deeply discounted valuations in 2023-24, notably with HIW, which delivered a +43% total return in 2024. Current leasing momentum, generationally low supply, and return-to-office trends support positive earnings growth for high-quality office REITs.
More office space is set to be removed than added this year, shrinking the overall office footprint. Office vacancies soared to a record high and still hover right around there at 19%.
PASADENA, Calif. , June 2, 2025 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced that its Board of Directors declared a quarterly cash dividend of $1.32 per common share for the second quarter of 2025.
PASADENA, Calif. , May 29, 2025 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced that the company will conduct a conference call and audio webcast on Tuesday, July 22, 2025 at 2:00 p.m.
PASADENA, Calif. , May 28, 2025 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative Megacampus⢠ecosystems in AAA life science innovation cluster locations, today celebrates the opening of the Alexandria Real Estate Equities, Inc. Learning Lab at the Fred Hutch Cancer Center, an innovative laboratory environment to inspire and train the next generation of scientists and advance Fred Hutch's rich legacy of research and development in cancer and other diseases.
Alexandria Real Estate Equities (ARE) is deeply undervalued, trading at just 9x AFFO and offering a nearly 8% dividend yield. Despite recent share price declines, ARE's fundamentals remain strong with high-quality assets, robust leasing, and a top-tier balance sheet. Management is proactively navigating headwinds with cost savings and capital recycling, while maintaining strong liquidity and long-term leases.
The market is not always efficient. This creates opportunities to buy diamonds at regular stone prices. In this article, I elaborate on my two favorite dividend bargains.
PASADENA, Calif. , May 27, 2025 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative Megacampus⢠ecosystems in AAA life science innovation cluster locations, continues to leverage its leadership position at the vanguard of the life science ecosystem to forge and strengthen strategic partnerships aimed at speeding and improving patient outcomes amid the nation's complex mental health crisis.
Life science REITs face headwinds from high interest rates and VC slowdown, but innovation and AI adoption signal long-term sector strength. Alexandria Real Estate stands out with a wide moat, high-quality tenants, strong balance sheet, and potential for 35% annualized returns if rates fall. Healthpeak benefits from diversified healthcare assets, robust leasing, and a strong balance sheet, offering a 25% return potential and monthly dividends.
REITs should do fine overall in the coming years. But some specific REITs should crush the rest of the market. Peak pessimism leads to massive opportunities. I explain how you can win big when investing in individual REITs.
The 10-Year Treasury yield signals that the market does not expect a recession in the near term. Current yield levels suggest inflation expectations remain elevated compared to recent years. Investors should interpret the bond market as pricing in persistent inflation rather than imminent economic contraction.